Cargando…

Influenza vaccination in patients affected by diabetes

Type 2 diabetes, obesity-related metabolic syndrome, and insulin resistance are the most common metabolic disorders associated with increased cardiovascular risk. In addition, patients with Type 2 diabetes have an increased risk for a more severe course of influenza virus infection, a common pandemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Verket, Marlo, Jacobsen, Malte, Schütt, Katharina, Marx, Nikolaus, Müller-Wieland, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021494/
https://www.ncbi.nlm.nih.gov/pubmed/36937371
http://dx.doi.org/10.1093/eurheartjsupp/suac119
_version_ 1784908500202160128
author Verket, Marlo
Jacobsen, Malte
Schütt, Katharina
Marx, Nikolaus
Müller-Wieland, Dirk
author_facet Verket, Marlo
Jacobsen, Malte
Schütt, Katharina
Marx, Nikolaus
Müller-Wieland, Dirk
author_sort Verket, Marlo
collection PubMed
description Type 2 diabetes, obesity-related metabolic syndrome, and insulin resistance are the most common metabolic disorders associated with increased cardiovascular risk. In addition, patients with Type 2 diabetes have an increased risk for a more severe course of influenza virus infection, a common pandemic. There is increasing evidence that influenza vaccination in patients with diabetes can safely and effectively reduce all-cause mortality and cardiovascular death. The effects of vaccination appear to be more effective when using higher-dose and quadrivalent vaccines, although subgroup-specific separate analyses in patients with diabetes are lacking. Clinical recommendations address influenza vaccination in all adults with diabetes. From our point of view, it should be an integral part of treatment strategies in patients with diabetes.
format Online
Article
Text
id pubmed-10021494
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-100214942023-03-18 Influenza vaccination in patients affected by diabetes Verket, Marlo Jacobsen, Malte Schütt, Katharina Marx, Nikolaus Müller-Wieland, Dirk Eur Heart J Suppl Influenza and cardiovascular outcomes – benefits of vaccination in the age of COVID 19? Supplement Paper Type 2 diabetes, obesity-related metabolic syndrome, and insulin resistance are the most common metabolic disorders associated with increased cardiovascular risk. In addition, patients with Type 2 diabetes have an increased risk for a more severe course of influenza virus infection, a common pandemic. There is increasing evidence that influenza vaccination in patients with diabetes can safely and effectively reduce all-cause mortality and cardiovascular death. The effects of vaccination appear to be more effective when using higher-dose and quadrivalent vaccines, although subgroup-specific separate analyses in patients with diabetes are lacking. Clinical recommendations address influenza vaccination in all adults with diabetes. From our point of view, it should be an integral part of treatment strategies in patients with diabetes. Oxford University Press 2023-02-14 /pmc/articles/PMC10021494/ /pubmed/36937371 http://dx.doi.org/10.1093/eurheartjsupp/suac119 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Influenza and cardiovascular outcomes – benefits of vaccination in the age of COVID 19? Supplement Paper
Verket, Marlo
Jacobsen, Malte
Schütt, Katharina
Marx, Nikolaus
Müller-Wieland, Dirk
Influenza vaccination in patients affected by diabetes
title Influenza vaccination in patients affected by diabetes
title_full Influenza vaccination in patients affected by diabetes
title_fullStr Influenza vaccination in patients affected by diabetes
title_full_unstemmed Influenza vaccination in patients affected by diabetes
title_short Influenza vaccination in patients affected by diabetes
title_sort influenza vaccination in patients affected by diabetes
topic Influenza and cardiovascular outcomes – benefits of vaccination in the age of COVID 19? Supplement Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021494/
https://www.ncbi.nlm.nih.gov/pubmed/36937371
http://dx.doi.org/10.1093/eurheartjsupp/suac119
work_keys_str_mv AT verketmarlo influenzavaccinationinpatientsaffectedbydiabetes
AT jacobsenmalte influenzavaccinationinpatientsaffectedbydiabetes
AT schuttkatharina influenzavaccinationinpatientsaffectedbydiabetes
AT marxnikolaus influenzavaccinationinpatientsaffectedbydiabetes
AT mullerwielanddirk influenzavaccinationinpatientsaffectedbydiabetes